BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7689820)

  • 1. The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage.
    Joshi N; Usuku K; Hauser SL
    Ann Neurol; 1993 Sep; 34(3):385-93. PubMed ID: 7689820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
    Martin R; Jaraquemada D; Flerlage M; Richert J; Whitaker J; Long EO; McFarlin DE; McFarland HF
    J Immunol; 1990 Jul; 145(2):540-8. PubMed ID: 1694881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules.
    Chou YK; Vainiene M; Whitham R; Bourdette D; Chou CH; Hashim G; Offner H; Vandenbark AA
    J Neurosci Res; 1989 Jun; 23(2):207-16. PubMed ID: 2474079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
    Salvetti M; Ristori G; D'Amato M; Buttinelli C; Falcone M; Fieschi C; Wekerle H; Pozzilli C
    Eur J Immunol; 1993 Jun; 23(6):1232-9. PubMed ID: 7684682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
    Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
    J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106.
    Martin R; Utz U; Coligan JE; Richert JR; Flerlage M; Robinson E; Stone R; Biddison WE; McFarlin DE; McFarland HF
    J Immunol; 1992 Mar; 148(5):1359-66. PubMed ID: 1371525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity.
    Jingwu Z; Medaer R; Hashim GA; Chin Y; van den Berg-Loonen E; Raus JC
    Ann Neurol; 1992 Sep; 32(3):330-8. PubMed ID: 1384421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein.
    Chou YK; Henderikx P; Vainiene M; Whitham R; Bourdette D; Chou CH; Hashim G; Offner H; Vandenbark AA
    J Neurosci Res; 1991 Feb; 28(2):280-90. PubMed ID: 1709690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
    Hermans G; Stinissen P; Hauben L; Van den Berg-Loonen E; Raus J; Zhang J
    Ann Neurol; 1997 Jul; 42(1):18-27. PubMed ID: 9225681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals.
    Jaraquemada D; Martin R; Rosen-Bronson S; Flerlage M; McFarland HF; Long EO
    J Immunol; 1990 Nov; 145(9):2880-5. PubMed ID: 1698864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects.
    Liblau R; Tournier-Lasserve E; Maciazek J; Dumas G; Siffert O; Hashim G; Bach MA
    Eur J Immunol; 1991 Jun; 21(6):1391-5. PubMed ID: 1710565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis.
    Utz U; Biddison WE; McFarland HF; McFarlin DE; Flerlage M; Martin R
    Nature; 1993 Jul; 364(6434):243-7. PubMed ID: 7686632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T lymphocyte response to myelin basic protein: selection of T lymphocyte lines from MBP-responsive donors.
    Vandenbark AA; Chou YK; Bourdette D; Whitham R; Chilgren J; Chou CH; Konat G; Hashim G; Vainiene M; Offner H
    J Neurosci Res; 1989 May; 23(1):21-30. PubMed ID: 2473214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
    Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
    Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.